Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8T0Z

Human liver-type glutaminase (K253A) with L-Gln, filamentous form

8T0Z の概要
エントリーDOI10.2210/pdb8t0z/pdb
EMDBエントリー40950
分子名称Glutaminase liver isoform, mitochondrial, GLUTAMINE (2 entities in total)
機能のキーワードmetabolic, cancer, hydrolase
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数12
化学式量合計797973.13
構造登録者
Feng, S.,Aplin, C.,Nguyen, T.-T.T.,Milano, S.K.,Cerione, R.A. (登録日: 2023-06-01, 公開日: 2024-03-13)
主引用文献Feng, S.,Aplin, C.,Nguyen, T.T.,Milano, S.K.,Cerione, R.A.
Filament formation drives catalysis by glutaminase enzymes important in cancer progression.
Nat Commun, 15:1971-1971, 2024
Cited by
PubMed Abstract: The glutaminase enzymes GAC and GLS2 catalyze the hydrolysis of glutamine to glutamate, satisfying the 'glutamine addiction' of cancer cells. They are the targets of anti-cancer drugs; however, their mechanisms of activation and catalytic activity have been unclear. Here we demonstrate that the ability of GAC and GLS2 to form filaments is directly coupled to their catalytic activity and present their cryo-EM structures which provide a view of the conformational states essential for catalysis. Filament formation guides an 'activation loop' to assume a specific conformation that works together with a 'lid' to close over the active site and position glutamine for nucleophilic attack by an essential serine. Our findings highlight how ankyrin repeats on GLS2 regulate enzymatic activity, while allosteric activators stabilize, and clinically relevant inhibitors block, filament formation that enables glutaminases to catalyze glutaminolysis and support cancer progression.
PubMed: 38438397
DOI: 10.1038/s41467-024-46351-3
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.3 Å)
構造検証レポート
Validation report summary of 8t0z
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon